BioNTech SE (LON:0A3M)
London flag London · Delayed Price · Currency is GBP · Price in USD
107.00
-10.45 (-8.90%)
At close: Apr 25, 2025

BioNTech SE Revenue

In the year 2024, BioNTech SE had annual revenue of 2.75B EUR, down -27.96%. BioNTech SE had revenue of 1.19B in the quarter ending December 31, 2024, a decrease of -19.54%.

Revenue
2.75B EUR
Revenue Growth
-27.96%
P/S Ratio
8.24
Revenue / Employee
406.25K EUR
Employees
6,772
Market Cap
18.74B GBP

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
Shell 227.10B
HSBC Holdings 44.89B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
British American Tobacco p.l.c. 25.87B
Rolls-Royce Holdings 18.91B
Revenue Rankings